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Atlanta, Georgia and Zurich, Switzerland
Objectives. The objective of this cots : t unication was to report
the long-term fotiow-up of all the patient treated by Dr. Andreas
Gruentzig in Zurich, Switzerland .
Background. The first patients to undergo percutaneous trans-
luminal coronary angioplasty bad the procedure performed by
Andreac ,ruentzig in Zurich between 1977 and 1980 . The method
of angioplasty has changed little, and the patients undergoing
these first procedures were similar to many patients undergoing
angioplasty today; therefore, their long-term outcome is of signif-
icant interest .
Methods
. All 169 patients with attempted angioplasty during
Gruentzig's years in Zurich have now been completely followed up
at 10 years . AN surviving patients were contacted directly or by
telephone interview, and the occurrence of each cardiac procedure
and coronary event was analyzed.
Results. One hundred thirty-three of the 169 patients under-
went successful angioplasty . Ten-year follow-up of this group
revealed an overall survival rate of 89.5%. The survival rate was
Andreas Gruentzig began experimenting with nondistensible
balloon material for improving on Dotter's coaxial catheter
technique for enlarging the lumen of atherosclerotic femoral
arteries in 1974 (1) . In 1976 he demonstrated in the dog
coronary model the ability to relieve an artificial coronary
obstruction using a catheter-based balloon sys!em . After
intraoperative demonstration of the catheter' ;, ~bB' : y to
enlarge the lumen in patients undergoing coronary artery
bypass surgery, with Richard Myler in San Francisco,
Gruentzig performed the first percutaneous transluminal
coronary angioplasty procedure at the University Hospital .
Zurich, on September 16, 1977. This dramatic development
was presented at the American Heart Association meeting in
November 1977 to a stunned audience. Gruentzig assisted
others in starting the technique, notably Martin Kaltenbach
in Frankfurt, Simon Stertzer in New York and Myler . Most
of the early patients, however, were treated by Gruentzig
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95% among patients with single-vessel disease and 81% among
those with multivessel disease
. Patients undergoing unsuccessful
dilation and those with failed angioplasty and subsequent bypass
surgery had a similar 10-year survival rate
. Angmgraphic re-
stenosis was present in 31% at 6 months
. Late restenosis between
6 months and 10 years occurred in eight patients
; however,
progression
of disease in undilated s'gments
occurred in 31
patients
. In addition to a better survival rate, patients with
single-vessel disease were less likely to have had bypass surgery
and were more likely to be angina free at the 10-year follow-up
than were patients with multivessel disease (79% vs . 67%).
Conclusions. This earliest angioplasty experience was also the
fn
st to demonstrate a difference in outcome between patients with
single-vessel and multivessel disease treated with angioplasty .
Although angioplasty is now performed in more complex patient
subsets, the long-term outcome of these "class!,. " angioplasty
patients should be applicable to similar patients tt
.ated today .
(J
Am Coll Cardiol IY93;22:35360)
himself at the University Hospital in Zurich ; where he taught
dozens of others through operative demonstrations . In Oc-
tober 1980 he left Zurich to join our group at Emor y
University.
During his time in Zurich, 169 patients underwent at ..
tempted angioplasty, and now the 10-year follow-up of all of
these patients has been completed. Coronary angioplasty
was originally used to treat proximal, relatively discrete
lesions because the equipment available for performing the
technique was suitable only in that situation (2-8) . The
procedure has hen expanded for use in patients with more
diffuse multivessel disease, and prospective randomized
trials are now underway to evaluate whether angioplasty is
comparable to surgery in such patients (9). However, many
patients currently treated do have the classic lesions similar
to those trea:ed with the very first angioplasty catheters . It is
therefore important to evaluate the long-term results in these
patients .
Methods
The method that Gruentzig used to perform coronary
angioplasty has been described elsewhere (2) and did not
change substantially over the period of his practice in
Zurich. Although the angioplasty balloon catheters have
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been improved over the years, the basic mechanism of
balloon angioplasty remains little changed at the present
time
. Patients selected for the procedure were symptomatic,
and frequently their symptoms were of recent onset . They
had predominantly single-vessel disease or, if they had
multivessel disease, one lesion was believed to be the
culprit . They had objective evidence of ischemia on exercise
testing and relatively proximal stenoses . Lesions considered
significant were those that reduced the diameter of the vessel
by ?50%, as determined by tracing the projected image of
the involved artery in multiple views, measuring the stenotic
segment compared with the adjacent normal-appearing seg-
ment and averaging the results . Multivessel disease was
defined as the occurrence of >50% diameter narrowing in
more than one of the three major coronary artery systems .
Single-vessel disease was present in 98 patients and
multivessel disease in 71 . Nineteen patients had previously
undergone bypass surgery . All patients were symptomatic
before angioplasty, and 97% had a positive exercise stress
test performed with a multistage bicycle ergometric proto-
col, as previously described (10) . Several studies have
documented the short-term and intermediate-term results of
coronary angioplasty in restoring coronary blood flow (11),
r.-lieving symptoms (12), improving left ventricular perfor-
mance (10,13) and improving exercise stress test results (10) .
The outcome of the first patients to undergo coronary
angioplasty in Zurich and their intermediate-term survival
and freedom from arterial reocclusion have been described
elsewhere (14) . The current study reports the 10-year
follow-up of all of these patients . This completed follow-up
provides a long-term evaluation of "classic" angioplasty
patients . We examined survival, cardiac mortality, event-
free survival, symptomatic status, angiographic recurrence
of stenosis and the need for repeat coronary angioplasty or
coronary artery bypass surgery .
Definition of primary success and recurrence. Primary
success was defined as reduction in vessel diameter narrow-
ing of ?20% points and a final stenosis of <50% . Recurrence
was defined as percent stenosis y50% found on repeat
angiography. Follow-up data were obtained by one of us
(M.S .) from a direct interview or telephone contact with all
patients and by collecting the results of laboratory tests,
including follow-up angiographic examinations . Angio-
graphic follow-up data were obtained in 96% of the patients
at a mean interval of 7 months after coronary angioplasty.
Statistical testing . All continuous variables are expressed
as mean value ± SD and were compared by analysis of
variance
. Categoric variables were compared by the chi-
square test . Survival rate was assessed with the method of
Kaplan and Meier
. All statistical testing was performed on a
Vax 11/750 computer using BMDP statistical software .
Results
Primary results . The in-hospital outcome of these pa-
tients has been previously reported
(14), and is summarized
Table l . Results of Angioplasty in 169 Patients
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here. Coronary angioplasty was performed in 169 patients at
the University of Zurich between September 1977 and Oc-
tober 1980. The average age of the patients at the time of
angioplasty was 49 .5 years, and 85% were men . Primary
success was achieved in 133 patients (79%), and in 36 the
procedure failed for technical reasons (Table 1) . Single-
vessel disease was present in 98 patients (58%) and multi-
vessel disease in 71 (42%) . Of the 36 patients in whom the
procedure failed because of technical problems, 32 under-
went coronary artery bypass grafting (on an emergency basis
in 13 and electively in l9) . Procedural complications occur-
ring in the hospital with the 169 first procedures and the 27
second attempts were 0 deaths, 5 Q-wave myocardial infarc-
tions, 13 emergency bypass operations, 10 elevations of
creatine kinase levels, I femoral artery aneurysm and I
femoral artery occlusion .
Follow-up of patients with a successful procedure . Of the
133 patients who had a technically successful procedure, all
survivors have now been followed up for 10 years (Table 2) .
Eighty-one patients had single-vessel disease and 52 multi-
vessel disease. There have been 14 deaths : 8 related to heart
disease, 4 due to cancer, I accidental and I of unknown
cause. During the follow-up period, 44 patients had angio-
graphic recurrence of the stenosis, and 27 of them underwent
a second arigioplasty . Twenty-five of the 27 second proce-
dures were technically successful, but 9 of the patients had a
second recurrence, and l died, leaving 15 with continued
success after the second procedure . Combining the 79 sur-
viving patients without an initial recurrence and the 15
surviving patients who had no recurrence after a second
angioplasty procedure results in 94 (71%) of the 133 patients
who are surviving with arteries free from angiographic
recurrence .
Anglograpldc restenosis . One hundred twenty-four (93%)
of the 133 patients underwent follow-up coronary angiogra-
Table 2. Follow-Up in 133 Patients With Successful Dilation
Unless otherwise indicated, data show number of patients.
Primary Result
Patients
(no .)
Success
133
Failure 36
Medical therapy 4
Elective coronary bypass surgery 19
Emergency coronary bypass surgery 13
Months of follow-up
I to 120
Long-term patency of dilated segment
94
Death
14
Recurrence of stenosis
44
Progression of disease in other vessels
31
Additional angioplasty procedures 31
Coronary artery bypass surgery
31
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phy up to approximately 6 months after angioplasty, and 38
recurrences (a 31% rate of recurrence in the patients restud-
ied) were demonstrated . Thirty-six patients with recurrence
of stenosis also had recurrence of angina, and two patients
were asymptomatic . Three of the 95 patients with no angio-
graphic recurrence had anginal pain .
Late angiographic evaluation . A second follow-up angio-
gram was obtained 2 to 10 years after angioplasty in 51
patients and demonstrated that late restenosis was uncom-
mon. Twenty-six patients returned in response to routine
requests and were asymptomatic, whereas the other 25
returned because of symptoms or signs of ischemia . Six
patients with patent dilated segments at 6-month restudy had
restenosis or; the late follow-up angiogram, and two patients
with an early recurrence and repeat coronary angioplasty
also had late restenosis . In addition, four patients with
patent arteries had their first follow-up angiogram >2 years
after angioplasty. Restenosis >2 years after angioplasty was
therefore observed in 8 of 55 patients in whom a late
angiogram was performed ; however, 35 patients who were
largely asymptomatic did not have a late follow-up angio-
gram. Stenoses that occurred late after angiography often
had more irregular borders and were longer than the original
lesions or the stenoses that occurred within 6 months,
making it difficult to establish whether these were actually
restenoses of the same lesions or new disease just adjacent
to those lesions . The eight patients with documented late
restenosis were treated with repeat coronary angioplasty (3),
coronary artery bypass surgery (4) and medication only (1) .
Progression . Progression of coronary artery disease in
nondilated sites without restenosis in the dilated site resulted
in obstruction :
ri
25 patients (14 with multivessel and 1 I with
single-vessel disease) . Ten of these patients underwent by-
pass surgery, 5 had angioplasty and 10 were treated medi-
cally. An additional six patients with restenosis also had
progression in another vessel . Five were treated with bypass
surgery and one medically .
Clinical follow-up of patients who had unsuccessful angio-
plasty. The 36 patients who had unsuccessful angioplasty
were also followed up. All but four underwent early bypass
surgery . We chose not to group these 36 patients with the
group that had successful dilation because primary success
rates in such patients would be much higher with the modern
equipment used today and the bypass surgery rate would be
much lower . There were three late deaths in the 36 patients
with unsuccessful dilation, a rate not different from that in
the patients with successful dilation .
Survival rate. The 10-year survival rate of the 133 pa-
tients who had technically successful angioplasty was
89.5%x: 95% among patients with single-vessel disease and
81% among those with multivessel disease. The cardiac
survival rate for the total group at 10 years was 94% .
Event-free survival. The 10-year freedom from a cardiac
event (death, myocardial infarction or coronary bypass
surgery) was 65% among the 133 patients with technically
successful procedures. Event-free survival was 74% (60 of
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81) among patients with single-vessel disease and 52% (27 of
52) among those with multivessel disease . When examined
for all cardiac events, including death, myocardial infarc-
tion, coronary artery bypass graft surgery or subsequent
coronary angioplasty for restenosis or progression of disei : ,e
elsewhere, we find 64 patients (48%) free from these events .
Symptomatic status. Of the 133 patients who had techni-
cally successful procedures, 84 were classified at the time of
the initial angioplasty in New York Heart Association func-
tional class III or IV . Eighty-nine patients (75% of those
surviving 10 years) remained asymptomatic at the last
follow-up interview, whereas none were asysmptomatic
before angioplasty. Seventy-nine percent (61 of 77) of the
patients with single-vessel disease were asymptomatic at
10 years compared with 67% (28 of 42) of those with
multivessel disease (Fig. 1). Of the 36 patients who had
technically unsuccessful procedures, 24 were in functional
class III or IV before angioplasty was attempted, and one
was still in class III and one in class IV at last follow-up
study . Fifteen were asymptomatic at last follow-up .
Comparison of patients with single-vessel and multivessel
disease. Although single-vessel dilation of culprit lesions
was the rule, there were a significant number of patients with
multivessel disease in Gruentzig's Zurich cohort . Interesting
differences emerge when comparing the single-vessel and
multivessel disease groups (Table 3) .
Ninety-eight patients had single-vessel disease and 71
multivessel disease. The primary success rates were 83% for
single-vessel disease and 73% for multivessel disease, and
the 10-year survival rate of the patients with successful
dilation was 95% for those with single-vessel and 81% for
those with multivessel disease (Fig . 2). Patients with single-
vessel disease were less likely to have myocardial infarction
(Fig. 3) and had a greater chance of surviving free from
infarction or bypass surgery . (Fig. 4). When all events,
including death, myocardial infarction, bypass surgery and
repeat coronary angioplasty were considered, there was only
a trend favoring single-vessel disease (Fig . 5) .
Restenosis of the dilated lesions did not differ between
groups, occurring in 32% (26 of $1) of those with singlc-
vessel disease undergoing follow-up angiography and 35%
(18 of 52) of those with multivessel disease undergoing
follow-up angiography ; however, long-terra angiographic
success, as judged by the absence of restenosis after the first
or second angioplasty procedure, and freedom from bypass
surgery and death occurred in 72% (58 of 81) of the patients
with single-vessel disease and 50%x (26 of 52) of the patients
with multivessel disease . Four of the patients with single-
vessel disease and six of the patients with multivessel
disease had late surgery because of progression of disease in
other vessels with maintained patency at the dilated site .
Progression of disease remote from the angioplasty site was
more likely in patients with multivessel disease (27% [14
patients]) than in those with single-vessel disease (14% [l I
patients]) . Freedom from angina at the 10-year follow-up
evaluation was 79% (61 of 77 sure ing patients) in the
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single-vessel group but only 67% (28 of 42 surviving patients)
in the multivessel group .
Among the 36 patients with unsuccessful dilation, 17 had
single-vessel disease, and 19 had multivessel disease. Two
patients with single-vessel disease continued on medical
Table 3. Ten-Year Follow-Up Results in 133 Patients With Single-
Vessel and Multivessel Disease Who Had Successful Dilation
Single-Vessel Multivessel
Disease
Disease
Data shown indicate number (%) of patients
.
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Figure 1 . Changes in New York Heart Association func-
tional classification of patients with single-vessel (A) and
multivessel (B) disease who had successful coronary an-
gioplasty (PTCA) . Post = after ; Pre = before .
therapy, and 15 had bypass surgery . One died after elective
bypass surgery, and two others had documented vein graft
closure. Two patients with multivessel disease continued on
medical therapy, and 17 had coronary bypass surgery . Ore
died 85 months after bypass surgery, and nine others had
documented closure of the vein grafts. Of these 36 patients
(32 had bypass surgery), 24 were in functional class III or IV
before attempted angioplasty, and 1 was still in functional
class III and I in functional class IV at last follow-up study .
Fifteen (eight with single-vessel disease and seven with
multivessel disease) remained asymptomatic at the last
follow-up examination .
Risk factors in the patients with successful dilation. At the
time of the last follow-up study, data were collected with
regard to the major risk factors for coronary artery disease .
Fifteen patients were treated for hypercholesierolemia, 10
for diabetes and 33 for hypertension . Only 8.3% were still
smoking, down from 71% at the time of the original angio-
plasty procedure .
(n=81) (n=52)
Death during follow-up period
4(5) 1009)
Recurrence of stenosis
26(32)
1805)
Progression of disease at undilated sites
11(14)
14(27)
Angioplasty during follow-up period
20
I I
Coronary artery bypass surgery during
follow-up period
16 15
Alive and angina free at 10 years
61(79)
28(54)
Discussion
Gruentzig et al . reported their first 50 patients in 1979 (2),
and we described this full cohort of patients with intermedi-
ate-term follow-up data ill 1987 (14) . Patients undergoing
angioplasty in this earliest experience reflected the selection
criteria that Gruentzig applied . Selection was heavily influ-
enced by the capability of the equipment available to him .
That equipment allowed dilation of proximal lesions predom-
inantly in the left anterior descending coronary artery, with
MI Free
Survival
Figure 3. Actuarial survival free trrm myocar-
dial infarction (MI) for patients with single-
vessel and multivessel disease . FF = freedom
from .
73% (123 of 169) of the procedures having been performed in
this artery (Fig . 6) .
The mix of patients undergoing angioplasty has changed
significantly over the years (4,15), so that approximately
50% of patients currently undergoing angioplasty have mul-
tivessel disease, usually of a more diffuse nature . Also a
significant number of patients undergoing angioplaasty (cur-
rently 25% of the Emory experience) have had previous
bypass surgery. Although angioplasty has been expanded in
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many high volume centers, many operators continue to limit
themselves to lesions similar to those originally described by
Gruentzig. In this report we have described the follow-up of
such patients in an effort to provide long-term observational
data that can be applied to similar patients treated at the
present time .
Although restenosis is largely a process of the healing
phase occurring within the 1st 6 months after angioplasty
(16), there are occasional instances of late closure of the
vessel that was originally dilated . The 6-month restenosis
rate of 31% compares favorably with data from many recent
angiographic follow-up studies (6,17-20) . Late restenosis,
I
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• in 20 21
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goccurrin  between 2 and 10 years after angioplasty, was
evaluated in studies performed in 55 patients . The finding
that eight of these patients had renarrowing or occlusion in
the arterial segment originally treated probably overesti-
mates the late restenosis rate . This is because total occlu-
sions or longer lesions make it impossible to determine
whether the new lesion was the original lesion or one just
adjacent to it . Long-term progression of disease, although
not systematically studied, was observed in these patients
and was more common in those with multivessel disease
than in thw,e who originally had single-vessel disease .
The main value of such follow-up study is its contribution
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Figure 4. Actuarial survival free from myocardial
infarction (MI) or coronary bypass surgery
(CABG) in patients with single-vessel and multi-
vessel disease . FF = freedom from .
Figure 5. Actuarial survival free from myocardial
infarction,
bypass surgery and repeat angioplasty
for patients with single-vessel and multivessel dis-
ease. FF = freedom from .
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to understanding of long-term clinical events. Previous
follow-up observations 5 years after angioplasty of patients
at Emory University (3) and in the National Heart, Lung,
and Blood Institute registry (21) show survival rates that are
excellent for patients with single-vessel disease and only
slightly worse for those with multivessel disease . Among the
patients at Emory undergoing angioplasty in 1981, the 5-year
survival rate was 97%. Almost 90% of these patients had
single-vessel disease . The survival rate at 10 years of the
Zurich patients with single-vessel disease is 95%, which is
higher than the 81% survival rate of the patients with
multivessel disease. Overall, the 89 .5% 10-year survival
rate gives an attrition of approximately 1%/year, which
is similar to the previous findings in shorter follow-up
series (14), that trend continues up to 10 years . Freedom
from the combined events of death, myocardial infarction or
the need for bypass surgery was 65% at 10 years among the
patients who had successful primary dilation . This figure
compares with the 79% freedom from the same events at 5
years in the Emory 1981 cohort. The survival rate of the
patiears with unsuccessful dilation followed by bypass sur-
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Figure 6. Left anterior descending coronary artery lesion before
(A), immediately after (s), 1 year after (C) and 10 years after
(D) angioplasty .
gery has been no lower than that of patients who had
successful dilation .
The symptomatic improvement of these patients has
continued to the 10-year mark. Seventy-nine percent of the
patients with single-vessel disease who were available for
10-year follow-up reported no angina compared with 67% of
those with multivessel disease.
Study limitations . The comparisons in this series of pa-
tients with single-vessel and multivessel disease suffer from
small numbers and the fact that single-vessel dilation was
performed in patients with multivessel disease. This gives an
indication of both the type of multivessel disease being
addressed and the philosophy of culprit vessel angioplasty
that was btin; followed, Nonetheless, important differences
emerged between the single-vessel and multivessel disease
groups, including improved long-term angiographic success
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without restenosis and less progression of disease in other
vessels and, perhaps because of these two factors, improved
survival and freedom from events in the single-vessel group .
This long-term follow-up from the very earliest days of
angioplasty provides a number of lessons that can be applied
to "classic" candidates for angioplasty currently being
treated. The 6-month restenosis rate is not different from
that found in similar patients being treated today. Although
comparisons with patients treated medically or surgically or
with new interventional devices are just now being made, it
will be several years before long-term follow-up data are
available from those trials . It is nevertheless reassuring that
patients with classic indications for balloon angioplasty have
done so well over the long term, particularly those with
single-vessel disease . This information will help guide prac-
tice until more definitive results from randomized trials are
available .
We are indebted to William S . Weintraub, MD for statistical analysis and to
Libby Adams for preparation of the manuscript .
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